
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
Jason Gerberry Maintained (TEVA) at Sell with Increased Target to $20 on, Nov 2nd, 2018


🞛 This publication is a summary or evaluation of another publication
Jason Gerberry of B of A Securities, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Increased Target from $19 to $20 on, Nov 2nd, 2018.
Jason has made no other calls on TEVA in the last 4 months.
There are 8 other peers that have a rating on TEVA. Out of the 8 peers that are also analyzing TEVA, 6 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ami Fadia of "Leerink Swann" Upgraded from Sell to Hold on, Monday, October 1st, 2018
- Tim Chiang of "BTIG" Upgraded from Strong Sell to Hold on, Monday, September 17th, 2018
- Vamil Divan of "Credit Suisse" Maintained at Hold with Increased Target to $26 on, Monday, September 17th, 2018
- Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $23 on, Monday, August 6th, 2018
- David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $20 on, Friday, August 3rd, 2018
- Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $25 on, Monday, July 16th, 2018
These are the ratings of the 2 analyists that currently disagree with Jason
- Jami Rubin of "Goldman Sachs" Maintained at Strong Buy and Held Target at $30 on, Monday, October 1st, 2018
- Irina Rivkind Koffler of "Mizuho" Maintained at Strong Buy with Increased Target to $29 on, Monday, September 17th, 2018
Similar Stocks and Investing Publications
[ Mon, Oct 01st 2018 ]: WOPRAI
[ Mon, Oct 01st 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Thu, Jan 18th 2018 ]: WOPRAI
[ Tue, Jan 09th 2018 ]: WOPRAI
[ Fri, Jan 05th 2018 ]: WOPRAI
[ Thu, Jan 04th 2018 ]: WOPRAI
[ Tue, Jan 02nd 2018 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI